Unicycive Therapeutics, Inc., (UNCY): Price and Financial Metrics

Unicycive Therapeutics, Inc., (UNCY): $0.50

0.03 (-6.52%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

B

Add UNCY to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#135 of 328

in industry

UNCY Price/Volume Stats

Current price $0.50 52-week high $1.82
Prev. close $0.54 52-week low $0.20
Day low $0.48 Volume 1,603,900
Day high $0.55 Avg. volume 1,182,594
50-day MA $0.40 Dividend yield N/A
200-day MA $0.80 Market Cap 47.19M

UNCY Stock Price Chart Interactive Chart >


Unicycive Therapeutics, Inc., (UNCY) Company Bio


Unicycive Therapeutics, Inc., a biotechnology company, engages in developing novel therapies for kidney diseases in the United States. It is developing Renazorb for treatment of hyperphosphatemia in patients with chronic kidney disease; and UNI 494, for treatment of acute kidney injury. The company was incorporated in 2016 and is based in Los Altos, California.


UNCY Latest News Stream


Event/Time News Detail
Loading, please wait...

UNCY Latest Social Stream


Loading social stream, please wait...

View Full UNCY Social Stream

UNCY Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!